Melena Due to Portal Colopathy or Portal Enteropathy
In a patient with portal hypertension presenting with melena, portal hypertensive gastropathy is the most common source of bleeding (2-12% of all GI bleeding in cirrhosis), while both portal enteropathy and colopathy are less common but important causes that typically present with chronic anemia rather than acute melena. 1
Understanding the Bleeding Sources
The 2022 EASL guidelines clearly establish that portal hypertensive gastropathy is the predominant non-variceal portal hypertensive bleeding source, though similar vascular lesions occur throughout the GI tract including the small bowel (portal enteropathy) and colon (portal colopathy) 1.
Key clinical distinction: These entities are mainly causes of chronic bleeding and chronic anemia rather than acute presentations 1. However, they can present as acute gastrointestinal bleeding, making the distinction clinically relevant.
Relative Likelihood Assessment
Portal Enteropathy (Small Bowel)
- Prevalence in portal hypertension: 40-70% 2
- Most common finding: Multiple angiodysplasias (63.6% of cirrhotic patients) 3
- In patients with suspected small bowel bleeding and Grade 2 portal enteropathy (vascular lesions), 66% had active small bowel bleeding at initial presentation 4
- Rebleeding rate at 1 year: 33% for Grade 2 lesions 4
Portal Colopathy
- Prevalence: Up to 71% in cirrhotic patients, though true prevalence uncertain due to lack of diagnostic criteria 5
- Classic study showed colorectal lesions in 70% of portal hypertension patients 6
- Overt bleeding occurred in only 4% of patients with colopathy 6
- Typically presents with subtle symptoms: iron deficiency anemia or intermittent rectal bleeding 5
Clinical Algorithm for Melena Evaluation
When melena is the presenting symptom:
First-line: Upper endoscopy to exclude gastric sources (portal hypertensive gastropathy accounts for 2-12% of GI bleeding in cirrhosis) 1
If upper endoscopy negative: Consider capsule endoscopy for small bowel evaluation
Risk factors favoring small bowel source (portal enteropathy):
- Colorectal angioectasia on colonoscopy
- Child-Pugh Grade C cirrhosis
- History of blood transfusion 4
Colonoscopy indicated when:
Management Approach
Regardless of the specific portal hypertensive source, the mainstay of treatment is portal pressure reduction 1:
Acute Setting
- Vasoactive therapy (terlipressin, octreotide, somatostatin) 1
- Restrictive transfusion strategy
- Address contributing factors (renal failure, infection, anemia)
Chronic Management
Important Caveat
Correction of coagulopathy (FFP, platelets, cryoprecipitate) is NOT routinely indicated for portal hypertensive bleeding and should only be considered on a case-by-case basis if portal pressure-lowering measures fail 1. This is critical because large-volume transfusions may paradoxically increase bleeding by raising portal pressure 1.
Common Pitfalls
- Assuming melena always indicates upper GI source: Small bowel lesions can present with melena, especially when bleeding is brisk
- Attributing bleeding to hemorrhoids or diverticular disease: PHC is frequently misdiagnosed 5
- Over-correcting coagulopathy: This can worsen portal hypertensive bleeding 1
- Missing the association: Portal colopathy strongly associates with portal gastropathy (P < .01) 6, so finding one should prompt evaluation for the other